FDA-Drug2024-04-24Class I
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
AvKARE
Hazard
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Sold states
US Nationwide.
Affected count
153 cartons
Manufactured in
615 N 1st St, Pulaski, TN, United States
Products
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0444-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief